Quantcast

Posts related to ‘Medical’

Potential Deathblow for Chelsea (CHTP)

Posted: March 29, 2012 at 9:20 am

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is being beaten hard this morning.  News hit that the FDA has now rejected the company's Northera drug to treat low blood pressure for ...
Read Full Story »

Globus Files For IPO, Profitable Medical Devices (GMED)

Posted: March 29, 2012 at 7:11 am

Globus Medical, Inc. is the latest of the companies filing with the Securities and Exchange Commission to come public via an initial public offering.  No terms were projected yet but ...
Read Full Story »

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Posted: March 19, 2012 at 11:11 am

Canadian-based drug company Cardiome Pharma Corp. (NASDAQ: CRME) announced this morning that Merck & Co. Inc. (NYSE: MRK) has cancelled further development of an oral version of a Cardiome drug ...
Read Full Story »

St. Jude, Device Maker Settle Royalty Dispute (STJ, KNSY)

Posted: March 19, 2012 at 10:58 am

St. Jude Medical Inc. (NYSE: STJ) has settled a royalty dispute with medical device maker Kensey Nash Corp. (NASDAQ: KNSY) over a device that St. Jude licensed from Kensey in ...
Read Full Story »

Alzheimer’s and the Economy

Posted: March 9, 2012 at 6:22 am

Many of the medical costs that Congress has begun to battle can be controlled. There is an argument this includes the cost of Medicare, Medicaid, drugs, doctor visits and preventable diseases. ...
Read Full Story »

Price of Drugs for the Elderly Soars

Posted: March 7, 2012 at 6:32 am

The AARP put out a remarkably complex research paper that shows, among other things, that the costs that people over 50 paid for commonly used drugs rose 25.6% between 2005 ...
Read Full Story »

The $28,000 Appendectomy

Posted: March 5, 2012 at 6:36 am

An organization called the International Federation of Health Plans keeps track of medical costs in most of the developed nations around the world. As would be expected, the costs for ...
Read Full Story »

VIVUS Scores FDA Backing For Qnexa Against Obesity (VVUS, OREX, ARNA)

Posted: February 22, 2012 at 4:36 pm

VIVUS, Inc. (NASDAQ: VVUS) is going to likely have a huge day on Thursday.  The FDA panel reviewing its Qnexa drug to treat obesity has voted overwhelmingly to offer FDA panel backing ...
Read Full Story »

J&J… When Beating Earnings Hits A Headwind (JNJ)

Posted: January 24, 2012 at 8:38 am

Johnson & Johnson (NYSE: JNJ) managed to marginally beat earnings expectations this Tuesday morning.  This is the first of the consumer products and medical products companies to report, so this ...
Read Full Story »

The $1,000 Genome Finally Arrives (LIFE)

Posted: January 10, 2012 at 11:47 am

Personalized medicine is coming... if you can afford it.  The quest for the $1,000 genomic map has been a race and it appears to be closer and closer.  News is out ...
Read Full Story »

It Takes a Recession to Slow U.S. Health Care Cost Increases

Posted: January 10, 2012 at 6:53 am

It takes a recession to slow what has normally been runaway U.S. health care costs. The trend may be part of a road map to keep costs down. These costs have risen ...
Read Full Story »

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

Posted: December 28, 2011 at 7:01 am

The biotech sector has seen its share of ups and downs in 2011 and prior years.  It is almost always the case that some of the top performing stocks each ...
Read Full Story »

Top Med-Tech Stock Picks for 2012 (BSX, ISRG, STJ)

Posted: December 21, 2011 at 5:06 pm

Many research firms have been coming up with their best ideas lists for 2012.  Today brought a list of top picks in the medical technology and medical devices sector from ...
Read Full Story »

Get Ready for a Pfizer Dividend Hike… A Holiday Gift From Big Pharma (PFE, MRK, WPI, TEVA)

Posted: December 8, 2011 at 11:14 am

We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks and months ahead.  Among those we expect to raise the ...
Read Full Story »

Dendreon Raising $125 Million Via I.P. Sale (DNDN, MRK)

Posted: December 6, 2011 at 12:45 pm

Dendreon Corporation (NASDAQ: DNDN) is supposed to be the king of prostate cancer with its PROVENGE treatment.  Unfortunately, PROVENGE sales ran slower than expected after the FDA took forever to ...
Read Full Story »